Farshad Farzadfar

Dados Biográficos

ID1840968
NOMEFarshad Farzadfar
PRENOMESFarshad
SOBRENOMEFarzadfar
ASSINATURAFARZADFAR F
AFILIAÇÕESTehran University of Medical Sciences
ORCID0000-0001-8288-4046
VERIFICADOSim
TOTAL DE OBRAS90
TOTAL DE CITAÇÕES1
TOTAL COMO AUTOR90
TOTAL COMO EDITOR0
PRIMEIRO ANO DE PUBLICAÇÃO2011
ANO MAIS RECENTE DE PUBLICAÇÃO2026
ÍNDICE H1

  • Prevalence, time trends and associated factors of adult overweight and obesity in 36 countries in the WHO African region from 2003 to 2022

    Open AccessMawuényégan Kouamivi Agboyibor, Kouamivi Mawuenyegan Agboyibor et al.ARTICLEBMJ Global Health2026

    BACKGROUND: We investigated the prevalence, temporal trends and associated factors of overweight and obesity among adults in the WHO African region. METHODS: We analysed individual-level data from 54 nationally/sub-nationally representative STEPS surveys conducted between 2003 and 2022 among adults aged 18-69 years. Prevalence estimates were weighted and age-standardised. Time trends were estimated using a Bayesian spatiotemporal modelling approa…

  • National, regional, and global trends in insufficient physical activity among adults from 2000 to 2022

    Open AccessTessa Strain, Seymour Flaxman et al.ARTICLEThe Lancet Global Health2024

    BACKGROUND: Insufficient physical activity increases the risk of non-communicable diseases, poor physical and cognitive function, weight gain, and mental ill-health. Global prevalence of adult insufficient physical activity was last published for 2016, with limited trend data. We aimed to estimate the prevalence of insufficient physical activity for 197 countries and territories, from 2000 to 2022. METHODS: We collated physical activity reported …

  • Global, regional, and national burden of disorders affecting the nervous system, 1990–2021

    Open AccessJaimie D Steinmetz, Katrin Seeher et al.ARTICLEThe Lancet Neurology2024

    BACKGROUND: Disorders affecting the nervous system are diverse and include neurodevelopmental disorders, late-life neurodegeneration, and newly emergent conditions, such as cognitive impairment following COVID-19. Previous publications from the Global Burden of Disease, Injuries, and Risk Factor Study estimated the burden of 15 neurological conditions in 2015 and 2016, but these analyses did not include neurodevelopmental disorders, as defined by…

  • Worldwide trends in underweight and obesity from 1990 to 2022

    Open AccessNowell H Phelps, Rosie Singleton et al.ARTICLEThe Lancet2024

    BACKGROUND: Underweight and obesity are associated with adverse health outcomes throughout the life course. We estimated the individual and combined prevalence of underweight or thinness and obesity, and their changes, from 1990 to 2022 for adults and school-aged children and adolescents in 200 countries and territories. METHODS: ). For school-aged children and adolescents, we report thinness (BMI 2 SD above the median). FINDINGS: From 1990 to 20…

  • Measuring The Harms Caused by Illicit Drugs. A New Methodology for Estimating Drug Harm Index

    Mohammad Hassan Novin, Emran M Razaghi et al.ARTICLESubstance Use & Misuse2024

    Background: Substance use carries a wide range of negative consequences, impacting both the individual using the substances and others. In recent years, there have been multiple efforts to assess the harm caused by drugs and to rank them, with each taking a distinctive approach to the matter. Objectives: This study seeks to introduce a new model for assessing the harm index and ranking of drugs. Methods: This prospective study involved the evalua…

  • Multiple cardiovascular risk factor care in 55 low- and middle-income countries

    Open AccessAlpha Oumar Diallo, Maja-Emilia Marcus et al.ARTICLEPLOS Global Public Health2024

    The prevalence of multiple age-related cardiovascular disease (CVD) risk factors is high among individuals living in low- and middle-income countries. We described receipt of healthcare services for and management of hypertension and diabetes among individuals living with these conditions using individual-level data from 55 nationally representative population-based surveys (2009–2019) with measured blood pressure (BP) and diabetes biomarker. We …

  • Burden of type 2 diabetes mellitus and its risk factors in North Africa and the Middle East, 1990–2019

    Open AccessNazli Namazi, Sahar Saeedi Moghaddam et al.ARTICLEBMC Public Health2024

    The burden of T2DM, in terms of mortality, DALYs, and YLDs, continues to rise in the region. The incidence rate of T2DM has increased in many areas. The burden of T2DM attributed to modifiable risk factors continues to grow in most countries. Targeting these modifiable risk factors could effectively reduce the growth and disease burden of T2DM in the region

  • Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050

    Open AccessKanyin Liane Ong, Lauryn K Stafford et al.ARTICLEThe Lancet2023

    BACKGROUND: Diabetes is one of the leading causes of death and disability worldwide, and affects people regardless of country, age group, or sex. Using the most recent evidentiary and analytical framework from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD), we produced location-specific, age-specific, and sex-specific estimates of diabetes prevalence and burden from 1990 to 2021, the proportion of type 1 and type 2 diabetes…

  • Physical activity pattern in Iran

    Open AccessSeyed Aria Nejadghaderi, Naser Ahmadi et al.ARTICLEFrontiers in Public Health2023

    Background Insufficient physical activity (IPA) is a significant risk factor for various non-communicable diseases. The Iran action plan is a 20% reduction in IPA. Therefore, we aimed to describe the age and sex pattern of physical activity domains, IPA, the intensity of physical activity, sedentary behavior, and their associates at Iran's national and provincial levels in 2021. Methods This study used the data of the STEPwise Approach to NCD Ris…

  • Effect of the chronic medication use on outcome measures of hospitalized Covid-19 patients

    Open AccessMohammad‐Reza Malekpour, Mohammad-Reza Malekpour et al.ARTICLEFrontiers in Public Health2023

    Background: Concerns about the role of chronically used medications in the clinical outcomes of the coronavirus disease 2019 (COVID-19) have remarkable potential for the breakdown of non-communicable diseases (NCDs) management by imposing ambivalence toward medication continuation. This study aimed to investigate the association of single or combinations of chronically used medications in NCDs with clinical outcomes of COVID-19. Methods: This ret…

  • Metabolic risk factors attributed burden in Iran at national and subnational levels, 1990 to 2019

    Open AccessSoroush Moradi, Amirhossein Parsaei et al.ARTICLEFrontiers in Public Health2023

    Introduction: Metabolic risk factors (MRFs) predispose populations to a variety of chronic diseases with a huge burden globally. With the increasing burden of these risk factors in Iran, in this study, we aimed to report the estimated burden attributed to MRFs at national and subnational scales in Iran, from 1990 to 2019. Methods: Based on the comparative risk assessment method of the Global Burden of Disease (GBD) Study 2019, data of deaths and …

  • The incremental cost of implementing the world health organization Package of essential non-communicable (PEN) diseases interventions in Iran

    Open AccessMehrdad Azmin, Farnam Mohebi et al.ARTICLEPLOS Global Public Health2023

    World-Health-Organization’s PEN package proposes a minimum set of cost-effective interventions for early diagnosis and management of Non-Communicable-Disease (NCD). IraPEN (the PEN package implemented in Iran), adopted from PEN and Iran National Action Plans for NCDs, addresses challenges regarding NCD prevention and control. IraPEN was piloted in four districts of Iran. In this research, we estimate incremental per-capita cost of IraPEN program …

  • Global, regional, and national burden and quality of care index (QCI) of bipolar disorder

    Open AccessParia Aghababaie-Babaki, Mohammad‐Reza Malekpour et al.ARTICLEInternational Journal of Social…2023

    BACKGROUND: Bipolar disorders (BD) are significant debilitating mental problems. Here, we introduced a novel index as a representative of the quality of care delivered to BD patients worldwide. METHODS: The Global Burden of Disease (GBD) 2019 study was the primary data source on BD, including prevalence, incidence, and years lived with disability (YLDs). Secondary indices were created and transformed into a single component that accounted for mos…

  • Sociodemographic differences in dietary trends among Iranian adults

    Open AccessSara Ebrahimi, Rebecca M Leech et al.ARTICLEPublic Health Nutrition2023

    Objective: To examine trends in the intake of key food groups among Iranian adults between 2005 and 2016, overall, and according to sociodemographic characteristics. Design: Repeat cross-sectional data from the Iran-STEPwise approach to risk factor surveillance (Iran-WHO STEPS) 2005–2016 were analysed. Regression analyses were used to evaluate trends in the frequency of fruits, vegetables and fish intake and type of oil used over time. Interactio…

  • Population-level risks of alcohol consumption by amount, geography, age, sex, and year

    Open AccessDana Bryazka, Marissa B Reitsma et al.ARTICLEThe Lancet2022

    BACKGROUND: The health risks associated with moderate alcohol consumption continue to be debated. Small amounts of alcohol might lower the risk of some health outcomes but increase the risk of others, suggesting that the overall risk depends, in part, on background disease rates, which vary by region, age, sex, and year. METHODS: For this analysis, we constructed burden-weighted dose-response relative risk curves across 22 health outcomes to esti…

  • Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019

    Open AccessGlobal Burden of Disease Cancer Collaboration, Jonathan Kocarnik et al.ARTICLEJAMA Oncology2022

    IMPORTANCE: The Global Burden of Diseases, Injuries, and Risk Factors Study 2019 (GBD 2019) provided systematic estimates of incidence, morbidity, and mortality to inform local and international efforts toward reducing cancer burden. OBJECTIVE: To estimate cancer burden and trends globally for 204 countries and territories and by Sociodemographic Index (SDI) quintiles from 2010 to 2019. EVIDENCE REVIEW: The GBD 2019 estimation methods were used t…

  • The effectiveness of fixed speed cameras on Iranian taxi drivers

    Open AccessMohammad‐Reza Malekpour, Mohammad-Reza Malekpour et al.ARTICLEFrontiers in Public Health2022

    Background: The adherence to speed limits can reduce deaths associated with road traffic injuries (RTIs) by more than a quarter. This study aimed to evaluate the effective factors on the speeding behavior of Iranian taxi drivers around fixed speed cameras. Method: Telematics devices used in this study collected the location and speed of the vehicles. The units of analysis in this study were trips per camera, including 2.5 km before and after each…

  • Regional burden of chronic kidney disease in North Africa and Middle East during 1990–2019; Results from Global Burden of Disease study 2019

    Open AccessOzra Tabatabaei-Malazy, Sahar Saeedi Moghaddam et al.ARTICLEFrontiers in Public Health2022

    Objectives: Updating burden data of chronic kidney disease (CKD) as one of the most prevalent non-communicable diseases is essential for proper provision of healthcare by policymakers. We aimed to estimate the burden of CKD and its attributed burden in North Africa and Middle East region (NAME) during 1990-2019. Methods: The CKD-related Global Burden of Disease (GBD) 2019 estimates were extracted from Health Metrics and Evaluation (IHME) website.…

  • Alcohol consumption and related disorders in Iran

    Open AccessNegar Rezaei, Naser Ahmadi et al.ARTICLEPLOS Global Public Health2022

    Background Alcohol consumption is a public health concern which is illegal in Iran. Moreover, due to cultural and religious beliefs, the available population-based research findings on alcohol consumption are inadequate. We aimed to provide an estimate on alcohol consumption using a large-scale population-based survey in Iran. Materials and methods The National Surveillance of Non-Communicable Risk Factors in Iran was a population-based survey co…

  • Inequality in prevalence, awareness, treatment, and control of hypertension in Iran

    Open AccessMahdi Mahdavi, Mahboubeh Parsaeian et al.ARTICLEBMC Public Health2022

    This study showed a pro-rich inequality in the prevalence and control of hypertension in Iran. We call for expanding the coverage of complementary insurance to reduce inequality of hypertension prevalence and control as compared with other factors it can be manipulated in short run. We furthermore advocate for interventions to reduce the inequality of hypertension control between rural and urban areas

  • Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health

    Open AccessKatherine R Paulson, Katherine Paulson et al.ARTICLEThe Lancet2021

    BACKGROUND: Sustainable Development Goal 3.2 has targeted elimination of preventable child mortality, reduction of neonatal death to less than 12 per 1000 livebirths, and reduction of death of children younger than 5 years to less than 25 per 1000 livebirths, for each country by 2030. To understand current rates, recent trends, and potential trajectories of child mortality for the next decade, we present the Global Burden of Diseases, Injuries, a…

  • Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to Vision 2020

    Open AccessJaimie D Steinmetz, Rupert R A Bourne et al.ARTICLEThe Lancet Global Health2021

    BACKGROUND: Many causes of vision impairment can be prevented or treated. With an ageing global population, the demands for eye health services are increasing. We estimated the prevalence and relative contribution of avoidable causes of blindness and vision impairment globally from 1990 to 2020. We aimed to compare the results with the World Health Assembly Global Action Plan (WHA GAP) target of a 25% global reduction from 2010 to 2019 in avoidab…

  • Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019

    Open AccessMarissa B Reitsma, Parkes J Kendrick et al.ARTICLEThe Lancet2021

    BACKGROUND: Ending the global tobacco epidemic is a defining challenge in global health. Timely and comprehensive estimates of the prevalence of smoking tobacco use and attributable disease burden are needed to guide tobacco control efforts nationally and globally. METHODS: We estimated the prevalence of smoking tobacco use and attributable disease burden for 204 countries and territories, by age and sex, from 1990 to 2019 as part of the Global B…

  • Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019

    Open AccessBin Zhou, Rodrigo M Carrillo-Larco et al.ARTICLEThe Lancet2021

    BACKGROUND: Hypertension can be detected at the primary health-care level and low-cost treatments can effectively control hypertension. We aimed to measure the prevalence of hypertension and progress in its detection, treatment, and control from 1990 to 2019 for 200 countries and territories. METHODS: We used data from 1990 to 2019 on people aged 30-79 years from population-representative studies with measurement of blood pressure and data on blo…

  • Global, regional, and national burden of stroke and its risk factors, 1990–2019

    Open AccessValery L Feigin, Benjamin A Stark et al.ARTICLEThe Lancet Neurology2021

    BACKGROUND: Regularly updated data on stroke and its pathological types, including data on their incidence, prevalence, mortality, disability, risk factors, and epidemiological trends, are important for evidence-based stroke care planning and resource allocation. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) aims to provide a standardised and comprehensive measurement of these metrics at global, regional, and national leve…